Commonly used
immunosuppressant drugs prevent rapid - onset, acute GVHD but not persistent, long - lasting, chronic GVHD, which may cause severe disability and death.
Not exact matches
In humans, Lagasse is banking on
immunosuppressant drugs to
prevent rejection.
Sutures across the implanted cornea temporarily held it in place, and the recipients were put on
immunosuppressant drugs for six weeks to
prevent it being rejected.
Rapamycin is an
immunosuppressant drug which can be used to help
prevent organ rejection after transplantation.
Inhibitory control Other strategies being pursued to
prevent the formation of inhibitors of clotting - factor therapy include
immunosuppressants and
drugs that deplete specific immune cells.
Following a tissue graft transplant — such as that of the face, hand, arm or leg — it is standard for doctors to immediately give transplant recipients
immunosuppressant drugs to
prevent their body's immune system from rejecting and attacking the new body part.
In 1994, Schreiber and co-workers discovered that the proteins FKBP12 and mTOR are the simultaneous targets of the small molecule rapamycin, now approved for use as an
immunosuppressant drug given to patients after organ transplantations to help
prevent rejection.
The
drug, rapamycin, is an
immunosuppressant used to treat certain cancers and also to
prevent organ rejection in transplant patients.